The Cancer Genome Atlas (TCGA) patient dataset shows significantly higher expression (P < 0.001) of ST6GalNAc-I in early-stage (n = 421) and late-stage (n = 110) LUAD samples compared with normal tissue adjacent to the tumor (NAT) (n = 59) (Figure 1C). The gene discussed is ST6GALNAC1; the disease is neoplasm.